Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Randomized, Open Label Trial of Orexin Receptor Antagonist for Insomnia in Hospitalized Patients With Cancer to Prevent Delirium

NCT06834386 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06834386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06834386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Randomized, Open Label Trial of Orexin Receptor Antagonist for Insomnia in Hospitalized Patients With Cancer to Prevent Delirium
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Withdrawn
Start date
February 26, 2025
Completion date
April 24, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid neoplasm, delirium, hematopoietic and lymphatic system neoplasm, insomnia